Abbott Laboratories
SIX:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
SIX:ABT
Watchlist
Price: 91.0424 CHF -4.17%
Market Cap: CHf239.4B

Net Margin

14.7%
Current
Declining
by 4.8%
vs 3-y average of 19.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
14.7%
=
Net Income
$6.5B
/
Revenue
$44.3B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
14.7%
=
Net Income
CHf6.5B
/
Revenue
$44.3B

Peer Comparison

Country Company Market Cap Net
Margin
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.3B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.6B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.2B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

Higher than 76% of companies in the United States of America
Percentile
76th
Based on 15 072 companies
76th percentile
14.7%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Abbott Laboratories
Glance View

Nestled into the landscape of global healthcare, Abbott Laboratories emerges as a stalwart that champions scientific innovation and broad accessibility. Established in 1888 by Dr. Wallace Calvin Abbott, the company evolved from a modest medicinal compounding business into a diversified healthcare conglomerate. Today, Abbott's reach extends across more than 160 countries, where it dedicates itself to advancing human health through a wide array of products, including diagnostics, medical devices, nutritionals, and branded generic medicines. This diverse portfolio enables Abbott to remain resilient amid varying market conditions, ensuring its stability and growth are less susceptible to the cyclical nature of any single healthcare segment. Central to Abbott's operations is its prowess in diagnostics and medical devices, both sectors contributing significantly to the company's bottom line. Diagnostics equip healthcare providers with advanced tools to detect diseases early, tailoring treatments to improve patient outcomes—a demand ballooning in tandem with global health awareness. Moreover, Abbott’s innovative medical devices, from cardiovascular to neuromodulation technologies, address some of the most pressing health challenges. Meanwhile, the company’s nutrition products, such as infant formulas and dietary supplements, tap into a burgeoning global appetite for health-conscious living. Each of these ventures feeds into Abbott's strategy of sustaining growth through constant innovation, strategic international expansion, and responsiveness to healthcare trends and needs worldwide. It's this blend of diversification and specialization that keeps the company at the forefront of the healthcare arena.

ABT Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
14.7%
=
Net Income
$6.5B
/
Revenue
$44.3B
What is Abbott Laboratories's current Net Margin?

The current Net Margin for Abbott Laboratories is 14.7%, which is below its 3-year median of 19.6%.

How has Net Margin changed over time?

Over the last 3 years, Abbott Laboratories’s Net Margin has decreased from 15.9% to 14.7%. During this period, it reached a low of 12.8% on Jun 30, 2023 and a high of 32.4% on Jun 30, 2025.

Back to Top